William Morano, MD
Surgical Oncology · Wynnewood, PANPI 1548609969
Payments from drug & device makers
What this record shows
This record is dominated by education: $10,305 of the $11,252 with a category attached, or 91.6%. Intuitive Surgical accounts for 92.4% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2023 at $6,222 and has fallen 95.4% since, to $286 in 2025. Among surgical oncology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 28 payments — averaging $401.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$10K
- Medical Device Business Services, Inc.$305
- AbbVie$128
- Boston Scientific$83
- Stryker$63
- Medtronic$53
- plus $228 from 10 others
What the payments were for
- Food & beverage$9478%
- Education$10,30592%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 10 | $10,392 |
| Medical Device Business Services, Inc. | 1 | $305 |
| AbbVie | 1 | $128 |
| Boston Scientific | 1 | $83 |
| Stryker | 2 | $63 |
| Medtronic | 2 | $53 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Merck | 1 | $27 |
| Incyte Corporation | 1 | $25 |
| AstraZeneca | 1 | $21 |
| Servier Pharmaceuticals LLC | 1 | $21 |
| Endomagnetics Ltd | 1 | $18 |
| KCI USA, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
| Seagen Inc. | 1 | $16 |
| Genmab U.S., Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$10,000
- ALLODERM$128
- Da Vinci Surgical System$102
How this compares
$11,252 in reported general payments places this provider in the 90th percentile of 78 surgical oncology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 14 | $23 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Wynnewood
- Arvind SabesanWynnewood$10K
- Robin CioccaWynnewood$4K
- Ned CarpWynnewood$3K
- Richard BleicherPhiladelphia$53K
- Catherine CarruthersSouthampton$17K
- Nestor EsnaolaPhiladelphia$17K
- Andrea PorpigliaPhiladelphia$11K
- Matthew HoltzmanPittsburgh$11K
- Stacy KrisherBensalem$9K
- Amer ZureikatPittsburgh$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.